Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yingqiang Zhang
Sorafenib Continuation or Discontinuation in Patients With Unresectable Hepatocellular Carcinoma After a Complete Response
Oncotarget
Oncology
Apatinib for Patients With Sorafenib-Refractory Advanced Hepatitis B Virus Related Hepatocellular Carcinoma: Results of a Pilot Study
Cancer Control
Medicine
Oncology
Hematology
Related publications
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
A Case of Hepatocellular Carcinoma With Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy After Sorafenib Failure
Journal of Liver Cancer
A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma
Internal Medicine
Internal Medicine
Medicine
Retrospective Analysis of Transarterial Chemoembolization and Sorafenib in Chinese Patients With Unresectable and Recurrent Hepatocellular Carcinoma
Oncotarget
Oncology
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Investigational New Drugs
Oncology
Pharmacology
Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Journal of Hepatocellular Carcinoma
Overall Survival in Response to Sorafenib Versus Radiotherapy in Unresectable Hepatocellular Carcinoma With Major Portal Vein Tumor Thrombosis: Propensity Score Analysis
BMC Gastroenterology
Medicine
Gastroenterology
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
